ÜBERMAB

Welcome to the Brand page for “ÜBERMAB”, which is offered here for Pharmaceutical preparations for use in ex vivo and in vivo treatment of cancer, inflammation and infectious diseases;.

Its status is currently believed to be active. Its class is unavailable. “ÜBERMAB” is believed to be currently owned by “SYNAGEVA BIOPHARMA CORP.”

Owner:
SYNAGEVA BIOPHARMA CORP.
Owner Details
Description:
Pharmaceutical preparations for use in ex vivo and in vivo treatment of cancer, inflammation and infectious diseases;
Categories: PHARMACEUTICAL PREPARATIONS USE